Home » Newsletters » BioWorld

BioWorld

Nov. 19, 1991

View Archived Issues

CEPHALON TO STUDY RETINAL DISEASES

TSI GETS GRANT FOR WATANABE RABBITS

MATRIX GETS INDs FOR CANCER DRUGS

MICROPROBE RAISES $2.9 MILLION

GENZYME'S r-GCR GETS ORPHAN DESIGNATION

PROTEIN DEVICE TO REPAIR FRACTURES

SCHERING SUES STERLING OVER IL-4

EARLY SUCCESS WITH OVARIAN CANCER DRUG

AURICULIN HELPS PREVENT KIDNEY TOXICITY

NOVEN GRANTS DELIVERY SYSTEM RIGHTS

CENTOCOR TO CO-DEVELOP MAbs WITH CORVAS

STOCKS REBOUND, BUT MAY HAVE PEAKED

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...